Financial statements Bioproten

Balance sheet of Bioproten

Company age:
Age:
7 y. 10 m. 18 d.
Share capital:
Share capital:
2 855 100 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of BIOPROTEN

Year
2018
2019
2020
2022
Total assets 41 160 099,05 48 968 785,85 65 048 763,06 85 631 302,31
A. Fixed assets 22 499 176,37 29 227 364,59 41 875 228,35 53 099 592,68
B. Current assets 18 660 922,68 19 741 421,26 23 173 534,71 32 531 709,63
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00
Total liabilities 41 160 099,05 48 968 785,85 65 048 763,06 85 631 302,31
A. Equity 4 105 015,26 10 263 877,48 24 426 861,50 21 398 184,13
B. Liabilities and provisions for liabilities 37 055 083,79 38 704 908,37 40 621 901,56 64 233 118,18
I. Long-term liabilities 9 741 701,51 11 517 544,74 14 803 205,30 30 507 470,28
II. Short-term liabilities 26 804 063,31 26 561 868,93 24 968 702,87 32 509 132,90
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.